Trials / Terminated
TerminatedNCT03382613
A Study to Quantify Use of Anticoagulation to Improve Management of Atrial Fibrillation
Quantify Use of Anticoagulation to Improve Management of AF
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (actual)
- Sponsor
- Janssen Scientific Affairs, LLC · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the impact of a hospital quality improvement (QI) program on the use of guideline-recommended oral anticoagulants (OAC) in hospitalized patients with atrial fibrillation (AF) at risk for ischemic stroke. Specifically, the study will determine whether the intervention, compared to Usual Care, will result in a greater increase in the proportion of patients with AF at risk for ischemic stroke who are appropriately treated with OAC.
Conditions
Timeline
- Start date
- 2017-12-29
- Primary completion
- 2019-12-03
- Completion
- 2019-12-03
- First posted
- 2017-12-26
- Last updated
- 2019-12-26
Locations
62 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03382613. Inclusion in this directory is not an endorsement.